| 000 | 01257 a2200349 4500 | ||
|---|---|---|---|
| 005 | 20250516175158.0 | ||
| 264 | 0 | _c20140430 | |
| 008 | 201404s 0 0 eng d | ||
| 022 | _a1476-5551 | ||
| 024 | 7 |
_a10.1038/leu.2013.311 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKharfan-Dabaja, M A | |
| 245 | 0 | 0 |
_aImmunotherapy for chronic lymphocytic leukemia in the era of BTK inhibitors. _h[electronic resource] |
| 260 |
_bLeukemia _cMar 2014 |
||
| 300 |
_a507-17 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAgammaglobulinaemia Tyrosine Kinase |
| 650 | 0 | 4 | _aCell Transplantation |
| 650 | 0 | 4 | _aHematopoietic Stem Cell Transplantation |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmune Tolerance _xdrug effects |
| 650 | 0 | 4 | _aImmunotherapy |
| 650 | 0 | 4 | _aLenalidomide |
| 650 | 0 | 4 |
_aLeukemia, Lymphocytic, Chronic, B-Cell _xtherapy |
| 650 | 0 | 4 |
_aProtein Kinase Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aProtein-Tyrosine Kinases _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aThalidomide _xanalogs & derivatives |
| 700 | 1 | _aWierda, W G | |
| 700 | 1 | _aCooper, L J N | |
| 773 | 0 |
_tLeukemia _gvol. 28 _gno. 3 _gp. 507-17 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/leu.2013.311 _zAvailable from publisher's website |
| 999 |
_c23199968 _d23199968 |
||